GE HealthCare, DeepHealth Expand Mammography Collaboration

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc., "to further the innovation, commercialization and adoption of advanced AI-powered mammography tools." 

The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium.

The expanded collaboration builds on the joint initiative first announced in 2024, which united DeepHealth’s AI-powered breast cancer screening workflow solution with GE HealthCare’s Senographe Pristina mammography system to enhance image interpretation and improve operational efficiency. This next phase of the joint initiative will extend the collaboration’s relationship for breast cancer solutions internationally, expanding the offering with second reader workflow and extending access to components of DeepHealth’s breast cancer solutions.¹

With the continued growth in capabilities of DeepHealth’s new Breast Suite² solution, GE HealthCare continues to bring to market an advanced, cloud-based suite of modular, interoperable applications that integrate seamlessly into existing breast imaging workflows. Paired with GE HealthCare’s Pristina Via, the combined offering enables scalable, high-efficiency breast cancer screening programs.

“At GE HealthCare, we’re advancing women’s health through precision care built around the unique needs of women and enhanced by the power of AI,” said Jyoti Gupta, PhD, President and CEO, Women’s Health and X-ray at GE HealthCare. “By integrating Breast Suite AI with our Pristina Via mammography system, we’re helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalized prevention and care for women.”

In the largest real-world analysis of AI-powered breast cancer screening in the U.S., a multistage AI-driven workflow from DeepHealth’s Breast Suite have shown to enable a 21% increase in breast cancer detection rate when compared to the standard of care³. Additionally, Breast Suite’s Timely Alerts features uniquely integrates with Pristina Via to notify sites of potentially suspicious cases in minutes.⁴  

“Pristina Via and Breast Suite have transformed how we approach breast cancer detection,” said Dr. Meghna Krishnan, Owner, URPrecious Imaging, Arizona. “The cloud-based viewer gives us instant access to images from anywhere, and the AI tools, like CAD for lesion detection and automated breast density assessment, can help us deliver fast and consistent results. It’s not just about speed, it’s about confidence. With Breast Suite, our team can make more accurate decisions without workflow disruptions, which ultimately means better care for our patients.”

The existing Breast Suite solution offered by GE HealthCare includes a cloud-first multi-modality Viewer, Cancer Detection, Automated Density Assessment, prioritized Worklist, Timely Alerts, and enhanced Reporting. The expanded collaboration will enable GE HealthCare to distribute new Breast Suite applications designed for compatibility with GE HealthCare’s mammography systems, including:

• ProFound Pro,⁵ which combines Cancer Detection, a clinical AI solution that offers automatic lesion localization and degree of suspicion that are effective in diverse populations and dense breast tissue, and Automated Density Assessment for consistent, automated density classification with a patient-centric, accurate density assessment of 2D or 3D mammograms to support objective diagnostic decisions.
• Safeguard Review⁶: OptionalAI-powered workflow that flags complex cases that may benefit from a secondary review. A large U.S. study demonstrate d a 21% increase in cancer detection rate and a 23% increase in cancer detection rate for women with dense breasts with a multistage AI-driven workflow when compared to the standard of care.¹

“At DeepHealth, we are committed to bringing the next era of AI-powered health informatics to help stage shift disease,” said Niccolo Stefani, MD, Business Leader Population Health & Clinical AI, DeepHealth. “Through our expanded collaboration with GE HealthCare, we are bringing the power of our new Breast Suite to providers around the world to enable early cancer detection, deeper clinical insights, and more confident decisions. Together we are pushing the boundaries of what mammography can deliver, not only for breast cancer screening but for women’s health more broadly.”

For more information, please visit https://deephealth.com/ and www.GEHealthCare.com

1. Certain components only available in the U.S.

2. Breast Suite comprises multiple applications including ProFound Pro, Breast Density, and DeepHealth Viewer. DeepHealth Viewer is manufactured by eRAD and distributed by DeepHealth. Not all components and functionality are available in all markets. Any claims made about Breast Suite may reference claims associated with its individual components.

3. Louis, L.D., Wakelin, E.A., McCabe, M.P. et al. Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment. Nature Health (2025). This study was conducted across 4 states with 579,583 exams, 109 sites, and 96 radiologists. The multistage AI-driven workflow leverages breast imaging specialists selected by breast imaging practice leadership based on experience and clinical performance record for secondary review. The standard of care is based on radiologists reading cases without any AI.

4. Data on file: Rapid image processing flags highly suspicion cases in under five minutes when integrated with GE HealthCare’s Senographe Pristina system and using 1 GB bandwidth transmission.

5. Not CE marked. Not available in all markets.

6. Only available in the U.S.